A startup can have interested investors and still struggle to finance its next stage. Several funds may offer small cheques, conditional on someone else leading. The round looks well supported until the founder asks who will set the terms and commit the remaining capital.
That distinction matters in European venture capital. A shortage of money overall, a shortage of large cheques and a shortage of investors willing to lead are different problems. Each calls for a different response.
What the evidence supports
The European Investment Bank's 2024 report The scale-up gap examined venture-backed companies that reached the scale-up phase in the EU after 2013, comparing them with peers in London and San Francisco. In its sample, EU companies had accumulated around half as much capital as their San Francisco peers by their tenth year. This is evidence of a financing gap among the companies studied, rather than a census of every European startup. EIB scale-up report.
The distinction between the EU and Europe is also material: the study treats London separately. Its findings should not be casually relabelled as statistics for the whole continent.
Nor does less capital, by itself, establish that every unfunded opportunity is attractive. Investors still need to distinguish a financing constraint from a business that has not earned its next round.
Four gaps that aggregate investment figures conceal
| Constraint | What a founder experiences | What would help |
|---|---|---|
| Lead-investor capacity | Interest without anyone underwriting the round | An investor able to price, diligence and anchor it |
| Cheque size | Existing backers cannot fund the next stage | Funds with suitable ticket and concentration limits |
| Funding duration | Capital lasts until a demonstration, but not commercial deployment | Financing matched to the full development cycle |
| Customer market scale | Expansion requires repeated country-by-country work | Easier access to customers, procurement and distribution |
These constraints can reinforce one another. Expensive expansion raises the financing requirement; a larger requirement narrows the investor pool. Calling the entire problem a lack of ambition misses that interaction.
A round can be popular and still be unfinanceable
Consider an illustrative company raising €40m to expand production. Two existing investors can each commit €5m. Neither will lead, and both require the full round to close.
The immediate gap is €30m plus a lead investor. Ten more introductions to funds with €1m ticket limits may produce useful relationships, but they do not necessarily solve the underwriting problem. Coordinating many conditional commitments may make the close harder.
Now suppose a €300m growth fund can invest up to 10% of commitments in one company, subject to its documents. Its maximum €30m cheque appears to fit. But if that limit must also accommodate future support, committing all €30m today could leave it unable to participate later.
The founder needs to understand the investor's capacity across the financing plan, not just its advertised initial cheque range. The same calculation helps an LP assess whether a new fund fills a real gap.
More venture money cannot repair every constraint
Imagine the company needs the €40m because it must duplicate commercial teams and adapt its product for several markets. Adding capital finances that work. It does not remove the underlying cost.
The EIB's recommendations extend beyond funding to the EU's internal market and skills. That makes the claim that capital is the sole constraint too strong, even when financing is a substantial one. EIB report and recommendations.
For an investor, the practical question is which barriers the company can overcome itself. A new sales hire may be within management's control; the timing of procurement reform is not. An investment case that depends on both should say so.
How to assess an opportunity within the gap
Start with a financing map: the amount required now, the milestone it buys, the likely next requirement and the investors capable of funding it. Identify which commitments are firm and which depend on another party.
Then test whether the proposed price compensates for the remaining uncertainty. A thin local funding market does not automatically make an investment cheap, and an overseas lead does not automatically make it expensive.
Finally, define the benefit of local capital precisely. Faster access to a board member, relevant customer introductions and a credible follow-on cheque can matter. A European address alone provides none of them. The strongest investment case connects a specific financing shortage to a company capable of using the money productively.
FAQ
Why can a European startup struggle to raise despite investor interest?
Interested funds may lack the cheque size, mandate or willingness to lead the round. Several offers can also depend on someone else completing the financing. Identify the missing role and binding commitments, rather than counting introductions or expressions of support as available capital.
Is late-stage funding Europe's only venture capital constraint?
No. Scale-up financing is a documented issue, but customer-market fragmentation, skills, procurement and exit conditions can also matter. Diagnose the company's specific bottleneck. More money may fund the work needed to cross a barrier without removing that barrier itself.
Do EU funding statistics include the UK?
Not necessarily. The EIB study discussed here compares EU scale-ups with London and San Francisco separately. Other datasets use different geographic definitions. Check the population and dates before applying a statistic labelled “EU” to all of Europe or comparing it with another report.
Can a cross-border syndicate fill a funding gap?
It can combine investors' capital and expertise, provided the commitments and structure are workable. It still needs a credible lead, sufficient total funding and a plan for later rounds. Investor eligibility, currency, governance and reporting must be resolved for the actual participants.
